Semaglutide Plus SGLT-2 Inhibitor Reduces HbA1c, Body Weight

Share this post

Semaglutide is an effective add-on treatment for patients whose type 2 diabetes is not well controlled on sodium-glucose cotransporter-2 (SGLT-2) inhibitors, new research shows.
Reuters Health Information

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply